GlassScriptPhysician profile
Diana Chu
NPI 1174149207
$12,029.90
in general payments reported to CMS, 2019-2025
26 companies · $2,313 in 2025
The $2,313 reported for 2025 was more than what 97% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $730 · 2022: $3,925 · 2023: $639 · 2024: $4,423 · 2025: $2,313.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,069 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,250 · Consulting Fee: $2,020 · Honoraria: $25.59 · Travel and Lodging: $10.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,069.27 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,250.00 |
| Consulting Fee | $2,020.00 |
| Honoraria | $25.59 |
| Travel and Lodging | $10.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $3,818.65 | 2022-2025 | Blink Nutritears, Xiidra, Miebo |
| Dompe US, INC. | $2,618.53 | 2021-2025 | Oxervate |
| Tarsus Pharmaceuticals, INC. | $1,237.65 | 2024-2025 | Xdemvy |
| Alcon Vision LLC | $1,142.99 | 2022-2025 | Rhopressa, Clareon Panoptix Pro, Clareon |
| Sun Pharmaceutical Industries INC. | $484.08 | 2022-2025 | Cequa |
| Biotissue Holdings INC. | $345.77 | 2022-2025 | |
| Kala Pharmaceuticals, INC. | $344.40 | 2021-2022 | |
| Aerie Pharmaceuticals, INC. | $322.79 | 2021 | |
| Johnson & Johnson Vision Care, INC. | $212.44 | 2022-2023 | Acuvue |
| Oyster Point Pharma, INC. | $207.08 | 2022-2025 | Tyrvaya, Ryzumvi |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $198.70 | 2021 | |
| Amgen INC. | $160.49 | 2024-2025 | Tepezza |
| Allergan, INC. | $149.39 | 2021-2022 | |
| Harrow Eye, LLC | $147.11 | 2025 | Vevye |
| Lkc Technologies, INC. | $120.53 | 2024-2025 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $110.86 | 2025 | Idosetr, Photrexa Viscous and Photrexa |
| Sight Sciences, INC. | $103.30 | 2022-2025 | Omni Surgical System |
| Rxsight INC | $90.31 | 2022-2024 | Light Adjustable Lens (Lal), Rxsight Contact Lens, Rxsight Injector Handpiece |
| Genentech USA, INC. | $43.27 | 2022-2023 | Vabysmo |
| Regeneron Healthcare Solutions, INC. | $37.56 | 2024 | Eylea Hd |
| Eyevance Pharmaceuticals LLC | $24.79 | 2023 | Flarex |
| Thea Pharma INC. | $24.41 | 2023 | Iyuzeh |
| Astellas Pharma US INC | $22.88 | 2023 | |
| Oasis Medical, INC. | $21.81 | 2022 | |
| Abbvie INC. | $21.30 | 2023 | Ozurdex |
| Novartis Pharmaceuticals Corporation | $18.81 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diana Chu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.